Literature DB >> 16636272

Lung dysfunction causes systemic hypoxia in estrogen receptor beta knockout (ERbeta-/-) mice.

Andrea Morani1, Rodrigo P A Barros, Otabek Imamov, Kjell Hultenby, Anders Arner, Margaret Warner, Jan-Ake Gustafsson.   

Abstract

Estrogen receptor beta (ERbeta) is highly expressed in both type I and II pneumocytes as well as bronchiolar epithelial cells. ERalpha is not detectable in the adult lung. Lungs of adult female ERbeta knockout (ERbeta-/-) mice have already been reported to have fewer alveoli and reduced elastic recoil. In this article, we report that, by 5 months of age, there are large areas of unexpanded alveoli in lungs of both male and female ERbeta-/- mice. There is increased staining for collagen and, by EM, abnormal clusters of collagen fibers are seen in the alveolar septa of ERbeta-/- mice. Immunohistochemical analysis and Western blotting with lung membrane fractions of ERbeta-/- mice revealed down-regulation of caveolin-1, increased expression of membrane type-1 metalloproteinase, matrix metalloproteinase 2 (active form), and tissue inhibitors of metalloproteinases 2. Hypoxia, measured by immunohistochemical analysis for hypoxia-inducible factor 1alpha and chemical adducts (with Hypoxyprobe), was evident in the heart, ventral prostate, periovarian sac, kidney, liver, and brain of ERbeta-/- mice under resting conditions. Furthermore, both male and female adult ERbeta-/- mice were reluctant to run on a treadmill and tissue hypoxia became very pronounced after exercise. We conclude that ERbeta is necessary for the maintenance of the extracellular matrix composition in the lung and loss of ERbeta leads to abnormal lung structure and systemic hypoxia. Systemic hypoxia may be responsible for the reported left and right heart ventricular hypertrophy and systemic hypertension in ERbeta-/- mice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16636272      PMCID: PMC1459034          DOI: 10.1073/pnas.0602194103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice.

Authors:  M Drab; P Verkade; M Elger; M Kasper; M Lohn; B Lauterbach; J Menne; C Lindschau; F Mende; F C Luft; A Schedl; H Haller; T V Kurzchalia
Journal:  Science       Date:  2001-08-09       Impact factor: 47.728

2.  A role for the androgen receptor in follicular atresia of estrogen receptor beta knockout mouse ovary.

Authors:  Guojun Cheng; Zhang Weihua; Sirpa Mäkinen; Sari Mäkelä; Shigehira Saji; Margaret Warner; Jan-Ake Gustafsson; Outi Hovatta
Journal:  Biol Reprod       Date:  2002-01       Impact factor: 4.285

3.  Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta.

Authors:  Yan Zhu; Zhao Bian; Ping Lu; Richard H Karas; Lin Bao; Daniel Cox; Jeffrey Hodgin; Philip W Shaul; Peter Thoren; Oliver Smithies; Jan-Ake Gustafsson; Michael E Mendelsohn
Journal:  Science       Date:  2002-01-18       Impact factor: 47.728

4.  Matrix metalloproteinases and tissue inhibitor of metalloproteinase-2 in fetal rabbit lung.

Authors:  Y Fukuda; M Ishizaki; Y Okada; M Seiki; N Yamanaka
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-09       Impact factor: 5.464

5.  Membrane-type 1 matrix metalloproteinase is required for normal alveolar development.

Authors:  Jeffrey J Atkinson; Kenn Holmbeck; Susan Yamada; Henning Birkedal-Hansen; William C Parks; Robert M Senior
Journal:  Dev Dyn       Date:  2005-04       Impact factor: 3.780

Review 6.  Involvement of gelatinases (MMP-2 and MMP-9) in the development of airway inflammation and pulmonary fibrosis.

Authors:  M Corbel; C Belleguic; E Boichot; V Lagente
Journal:  Cell Biol Toxicol       Date:  2002       Impact factor: 6.691

7.  Distinctive functions of membrane type 1 matrix-metalloprotease (MT1-MMP or MMP-14) in lung and submandibular gland development are independent of its role in pro-MMP-2 activation.

Authors:  Samantha A Oblander; Zhongjun Zhou; Beatriz G Gálvez; Barry Starcher; John M Shannon; Madeleine Durbeej; Alicia G Arroyo; Karl Tryggvason; Suneel S Apte
Journal:  Dev Biol       Date:  2005-01-01       Impact factor: 3.582

8.  Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF.

Authors:  M T Henry; K McMahon; A J Mackarel; K Prikk; T Sorsa; P Maisi; R Sepper; M X Fitzgerald; C M O'Connor
Journal:  Eur Respir J       Date:  2002-11       Impact factor: 16.671

9.  Molecular cloning of murine 72-kDa type IV collagenase and its expression during mouse development.

Authors:  P Reponen; C Sahlberg; P Huhtala; T Hurskainen; I Thesleff; K Tryggvason
Journal:  J Biol Chem       Date:  1992-04-15       Impact factor: 5.157

Review 10.  Matrix metalloproteinases in lung biology.

Authors:  W C Parks; S D Shapiro
Journal:  Respir Res       Date:  2000-12-29
View more
  49 in total

1.  Targeting the estrogen pathway for the treatment and prevention of lung cancer.

Authors:  Timothy F Burns; Laura P Stabile
Journal:  Lung Cancer Manag       Date:  2014-02-01

2.  Expression levels of estrogen receptor beta in conjunction with aromatase predict survival in non-small cell lung cancer.

Authors:  Vei Mah; Diana Marquez; Mohammad Alavi; Erin L Maresh; Li Zhang; Nam Yoon; Steve Horvath; Lora Bagryanova; Michael C Fishbein; David Chia; Richard Pietras; Lee Goodglick
Journal:  Lung Cancer       Date:  2011-04-20       Impact factor: 5.705

3.  Role of estrogen receptor beta in uterine stroma and epithelium: Insights from estrogen receptor beta-/- mice.

Authors:  Osamu Wada-Hiraike; Haruko Hiraike; Hiroko Okinaga; Otabek Imamov; Rodrigo P A Barros; Andrea Morani; Yoko Omoto; Margaret Warner; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-16       Impact factor: 11.205

4.  Estrogen receptor beta (ERbeta) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells.

Authors:  Pamela A Hershberger; Laura P Stabile; Beatriz Kanterewicz; Mary E Rothstein; Chris T Gubish; Stephanie Land; Yongli Shuai; Jill M Siegfried; Mark Nichols
Journal:  J Steroid Biochem Mol Biol       Date:  2009-05-19       Impact factor: 4.292

5.  Xanthine oxidoreductase depletion induces renal interstitial fibrosis through aberrant lipid and purine accumulation in renal tubules.

Authors:  Toshio Ohtsubo; Kiyoshi Matsumura; Kanae Sakagami; Koji Fujii; Kazuhiko Tsuruya; Hideko Noguchi; Ilsa I Rovira; Toren Finkel; Mitsuo Iida
Journal:  Hypertension       Date:  2009-08-10       Impact factor: 10.190

6.  Estrogen receptor β exon 3-deleted mouse: The importance of non-ERE pathways in ERβ signaling.

Authors:  Laure Maneix; Per Antonson; Patricia Humire; Sabrina Rochel-Maia; Jessica Castañeda; Yoko Omoto; Hyun-Jin Kim; Margaret Warner; Jan-Åke Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-06       Impact factor: 11.205

Review 7.  Estrongenic steroid hormones in lung cancer.

Authors:  Jill M Siegfried; Laura P Stabile
Journal:  Semin Oncol       Date:  2013-12-12       Impact factor: 4.929

8.  Hypoxia-activated cytotoxic agent tirapazamine enhances hepatic artery ligation-induced killing of liver tumor in HBx transgenic mice.

Authors:  Wei-Hsiang Lin; Shiou-Hwei Yeh; Kun-Huei Yeh; Kai-Wei Chen; Ya-Wen Cheng; Tung-Hung Su; Ping Jao; Lin-Chun Ni; Pei-Jer Chen; Ding-Shinn Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-04       Impact factor: 11.205

9.  Induction of trefoil factor (TFF)1, TFF2 and TFF3 by hypoxia is mediated by hypoxia inducible factor-1: implications for gastric mucosal healing.

Authors:  C Hernández; E Santamatilde; K J McCreath; A M Cervera; I Díez; D Ortiz-Masiá; N Martínez; S Calatayud; J V Esplugues; M D Barrachina
Journal:  Br J Pharmacol       Date:  2008-12-09       Impact factor: 8.739

10.  Estrogen receptor β, a regulator of androgen receptor signaling in the mouse ventral prostate.

Authors:  Wan-Fu Wu; Laure Maneix; Jose Insunza; Ivan Nalvarte; Per Antonson; Juha Kere; Nancy Yiu-Lin Yu; Virpi Tohonen; Shintaro Katayama; Elisabet Einarsdottir; Kaarel Krjutskov; Yu-Bing Dai; Bo Huang; Wen Su; Margaret Warner; Jan-Åke Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.